BIOACTIVITY OF PHENOLIC COMPOUNDS FROM PEANUT SKIN AFTER IN VITRO DIGESTION

Favoritar este trabalho
Como citar esse trabalho?
Detalhes
  • Tipo de apresentação: Pôster
  • Eixo temático: Alimentação e saúde (AS)
  • Palavras chaves: Antioxidants; phenolic compounds; peanut skin;
  • 1 Faculdade de Saúde Pública, Universidade de São Paulo
  • 2 Faculdade de Saúde Pública / Universidade de São Paulo
  • 3 Nutrition / School of Public Health / Universidade de São Paulo
  • 4 Department of Nutritional Sciences / College of Allied Health, University of Oklahoma Health Sciences Center – Oklahoma, United States / University of Oklahoma Health Sciences Center – Oklahoma, United States
  • 5 Laboratory of Antioxidants / Nutrition and Food Technology Institute / University of Chile
  • 6 Departamento de Ciencias Vegetales / Facultad de Agronomía e Ingeniería Forestal / Pontificia Universidad Católica de Chile
  • 7 Nutrição / Faculdade de Saúde Pública / Universidade de São Paulo

BIOACTIVITY OF PHENOLIC COMPOUNDS FROM PEANUT SKIN AFTER IN VITRO DIGESTION

Karina Silva Cordeiro

Faculdade de Saúde Pública, Universidade de São Paulo

Resumo

Peanut skin, a byproduct of peanut processing, contains biologically active phenolic compounds. Herein, we evaluated the bioactivity of digested peanut skin extracts using several parameters. Samples were called aquous extract, phase 1 and phase 2. In phase 1, powdered peanut skin was submitted to simulated oral-gastroduodenal digestion using α-amylase, pepsin, pancreatin, lipase, and bile salts. In phase 2, the digested extract from phase 1 was submitted to simulated colonic digestion using a mixture of carbohydrate-hydrolyzing enzymes. Total phenolic content was determined using the Folin–Ciocalteu method. Phenolic compounds were identified using high-performance liquid chromatography. Antioxidant activity was evaluated using different assays. Enzymatic inhibition was determined for pancreatic lipase and α-glucosidase. Finally, viability of HCT116 cells was monitored. The extracts contained caffeic, coumaric, quinic, protocatechuic, ferulic, ellagic, and gallic acids; quercetin; catechin; epicatechin; B-type procyanidins; and caffeine. Phase 1 (16.1 mg GAE/g of sample) and phase 2 (6.6 mg GAE/g of sample) extracts had lower total phenolic content than the aqueous extract (68.5 mg GAE/g of sample), while the phenolic profile remained similar among the three samples. Phase 1 extract had greater antioxidant activity than phase 2 extract, as evidenced by ORAC (128.97 vs 53.50 µM TE/ g of sample), DPPH (IC50 values of 54.5 vs 176.0 mol TE/g of sample, and FRAP (7.02 vs 2.13 mg GAE/g of sample) values. The half-maximal inhibitory concentrations (IC50) of phase 1 and 2 extracts for pancreatic lipase were 11 and 135 µg of sample/mL, respectively; for α-glucosidase, they were 7 and 33 µg of sample/mL, respectively. The IC50 of cellular viability were 9.4 and 15.9 mg of sample/mL for phase 1 and 2 extracts, respectively. Simulated digestion of phenolic compounds from peanut skin resulted in extracts with important biological activity and without cell toxicity. This common byproduct has potential applications in human health.

Questões (3 tópicos)

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Autor

Karina Silva Cordeiro

Obrigada. Buscamos fazer um bom apanhado de análises para um resultado mais fidedigno.

Amanda Mellissa B Oliveira

Obrigada pela resposta e boa sorte nos seus próximos trabalhos! :)